In 2005 DELTA got the idea to make an electronic patch and the actual work and research took off in 2007.
In 2007 DELTA took the first step to establish an innovation consortium with seven other partners: four private companies, two public universities, and a public hospital in total.
This consortium was approved by the Danish Council for Technology and Innovation and funded by the Danish Agency for Science, Technology and Innovation.
The purpose of the consortium was to develop a technological platform shaped as an electronic patch that could meet several medical-related demands.
The collaboration resulted in a real life test with heart patients at the Hospital of Frederikshavn, Denmark.
In 2008-2012 DELTA was supported by the Danish Public Welfare Technology Fund, and with this funding we were able to make studies of heart patients and to test them at the cardiological ward at the Danish Hospital of Svendborg.
The ePatch® business unit was acquired and became part of the US leader in home monitoring of cardiac patients, BioTelemetry Inc. (BEAT on NASDAQ), and continue under the name of BioTelemetry Technology ApS.